Alexion Pharmaceuticals

+$3.05 (+1.70%) Today
$0.00 (0.00%) As of 11:21 PM UTC after-hours

Why Robinhood?

You can watch ALXN and buy or sell other stocks, options, and ETFs commission-free!

About ALXN

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH).

CEO
Marc Pierre Jean Dunoyer, MBA
Employees
—
Headquarters
Boston, Massachusetts
Founded
1992

ALXN Key Statistics

Market cap
40.34B
Price-Earnings ratio
59.70
Dividend yield
—
Average volume
14.86M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$187.45
52 Week low
$99.91

ALXN Earnings

$0.00
$1.17
$2.35
$3.52
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure